Although differential expression of 421 genes has been documented in the development of fibromyalgia (e.g., HDC, GATA2, and APBB2), genome-wide expression profiling in patients with fibromyalgia did not reveal any alterations within the ECS [116]. This evidence concerns the gene APBB2 and fibromyalgia.